Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-08-05
1995-01-17
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514466, 514471, 514657, 549426, 549433, 549451, 564428, A61K 3135, A61K 3136, A61K 31135, C07D31500, C07D31770, C07D21100
Patent
active
053825969
ABSTRACT:
Optically active or racemic compounds represented by the formula ##STR1## where R.sub.2 is OA and R.sub.3 is selected from the group consisting of H and OA; where A is H or is selected from the group consisting of hydrocarbyl radicals comprising between 1 and 3 carbon atoms, as well as ##STR2## with the proviso that when R.sub.3 is OA, then R.sub.2 and R.sub.3 may be bonded together to form the group R.sub.4 is selected from the group consisting of alkyl and aromatic residues having from 1 to 20, preferably from 1 to 12, carbon atoms, for example, alkyl, optionally substituted with aromatic residues, and aromatic residues optionally substituted with alkyl radicals; n is an integer from 1 to 4; R.sub.5 is an unbranched alkyl chain comprising from 1 and 3 carbon atoms or a cyclopropylmethyl radical; R.sub.1 is alkoxy, cycloalkoxy and a cyclic ether of the formula ##STR3## where m is an integer from 3 to 5; with the proviso that when R.sub.1 is alkoxy, then R.sub.3 cannot be H; and pharmaceutically-acceptable salts thereof.
These compounds are useful for alleviating Parkinsonism, glaucoma, hyperprolactinemia and for inducing weight loss in mammals.
REFERENCES:
patent: 3296249 (1967-01-01), Bell
patent: 3930022 (1975-12-01), Hauck et al.
patent: 3991207 (1976-11-01), Sarges et al.
patent: 4010202 (1977-03-01), Sugihara et al.
patent: 4035512 (1977-07-01), Sugihara et al.
patent: 4057582 (1977-11-01), Dunnigan et al.
patent: 4076843 (1978-02-01), Hauck et al.
patent: 4267373 (1981-05-01), Hauck et al.
patent: 4410519 (1983-10-01), Seiler et al.
patent: 4564628 (1986-01-01), Horn
patent: 4722933 (1988-02-01), Horn
patent: 5068325 (1991-11-01), Grell et al.
Santangelo et al, CA 120(9)=106565z (1993).
Hook et al, CA 120(1)=8264f (1993).
Peck et al, CA 115(3)=28926y (1991).
Horn, CA 111(1)=753h (1988).
Chiesi et al, CA 100(23)=191603q (1983).
Cannon et al, J. Med. Chem. 24(2), 149-53 (1981)--only Chem Abst. is provided.
McDermed et al. J. Med. Chem., 18(4), 362-367 (1975).
McDermed et al., J. Med. Chem., 19(4), 547-549 (1976).
Hacksell et al., J. Med. Chem., 22(12), 1469-1475 (1979).
Seiler et al., J. Med. Chem., 29, 912-917 (1986).
Munson et al., Analytical Biochemistry, 107, 220-239 (1980).
Minaskanian Gevork
Moses L. Meredith
Sleevi Mark C.
Tsang Cecilia
Whitby Research, Inc.
LandOfFree
Substituted 2-aminotetralins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2-aminotetralins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-aminotetralins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-747284